Disclosures for "A Phase 1, First-in-human, Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Intravenous Dose Study of a novel TREM2 agonist (VGL101) in Healthy Volunteers (HVs)")
-
Dr. Papapetropoulos has received personal compensation for serving as an employee of Vigil Neuroscience . Dr. Papapetropoulos has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Acadia. Dr. Papapetropoulos has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ventus Therapeutics Inc. Dr. Papapetropoulos has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Adamas Pharmaceuticals. Dr. Papapetropoulos has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Lipocine Inc. Dr. Papapetropoulos has stock in Vigil Neuroscience. Dr. Papapetropoulos has stock in Adamas. Dr. Papapetropoulos has stock in Lipocine.
-
Andreas Meier has received personal compensation for serving as an employee of Voyager Therapeutics. Andreas Meier has received personal compensation for serving as an employee of Biogen.
-
Mr. O'Mara has received personal compensation for serving as an employee of VIgil Neuroscience, LLC.
-
Mr. Marsh has received personal compensation for serving as an employee of Vigil Neuroscience, Inc.. Mr. Marsh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vigil Neuroscience, Inc..
-
Dr. Neelon has received personal compensation for serving as an employee of BridgeBio. Dr. Neelon has received personal compensation for serving as an employee of Vigil NeuroScience. An immediate family member of Dr. Neelon has received personal compensation for serving as an employee of Crisper Therapeutics. An immediate family member of Dr. Neelon has received personal compensation for serving as an employee of Mana Therapeutics. Dr. Neelon has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for BridgeBio. Dr. Neelon has stock in BridgeBio. Dr. Neelon has stock in VigilNeuro Science. An immediate family member of Dr. Neelon has stock in Cripser Therapeutics. An immediate family member of Dr. Neelon has stock in Mana Therapeutics. Dr. Neelon has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Rajagovindan has received personal compensation for serving as an employee of Biogen. Dr. Rajagovindan has received personal compensation for serving as an employee of Vigil. Dr. Rajagovindan has stock in Biogen. Dr. Rajagovindan has stock in Vigil .
-
Dr. Thackaberry has received personal compensation for serving as an employee of Vigil Neuroscience. Dr. Thackaberry has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Samsara Biocapital. Dr. Thackaberry has stock in Vigil Neurosciences.
-
Dr. Stiles has received personal compensation for serving as an employee of Vigil Neuroscience. Dr. Stiles has received personal compensation for serving as an employee of Vertex Pharmaceuticals.